Danaher Strikes $10 Billion Deal for Masimo

Core Viewpoint - The medical-device maker is anticipated to function as an independent entity within Danaher's Diagnostics segment [1] Group 1 - The company will operate as a stand-alone business, indicating a strategic focus on its specific market segment [1]